the efficacy data, and the safety data. our fda particularly when it comes to children, are very very scrupulous in figuring out whether or not we have a benefit risk ratio that is favorable for the benefit. and it clearly came out with that. and that is the reason why they authorized it, and that is the reason why we had 14 to 0 recommendation from the advisory committee on immunization practices whose job is to look out for both the safety of the children, as well as the protection from the vaccine. so we have to get that message across to parents, and not put down or be put off by those very valid questions. we'd like them to add questions, we believe we have the data to back up the answer. >> the vaccination for kids ages 5 to 11, obviously there are kids ages four kids younger than five, it shocked me in that respect. in some point in my life, i hope, we are not going to be